These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 27569032)
1. A biodistribution study of solid lipid-polyethyleneimine hybrid nanocarrier for cancer RNAi therapy. Xue HY; Tran N; Wong HL Eur J Pharm Biopharm; 2016 Nov; 108():68-75. PubMed ID: 27569032 [TBL] [Abstract][Full Text] [Related]
2. Targeted nanomedicine for prostate cancer therapy: docetaxel and curcumin co-encapsulated lipid-polymer hybrid nanoparticles for the enhanced anti-tumor activity in vitro and in vivo. Yan J; Wang Y; Zhang X; Liu S; Tian C; Wang H Drug Deliv; 2016 Jun; 23(5):1757-62. PubMed ID: 26203689 [TBL] [Abstract][Full Text] [Related]
3. Solid lipid-PEI hybrid nanocarrier: an integrated approach to provide extended, targeted, and safer siRNA therapy of prostate cancer in an all-in-one manner. Xue HY; Wong HL ACS Nano; 2011 Sep; 5(9):7034-47. PubMed ID: 21838301 [TBL] [Abstract][Full Text] [Related]
4. TAT modified and lipid - PEI hybrid nanoparticles for co-delivery of docetaxel and pDNA. Dong S; Zhou X; Yang J Biomed Pharmacother; 2016 Dec; 84():954-961. PubMed ID: 27764758 [TBL] [Abstract][Full Text] [Related]
5. Lipidoid-polymer hybrid nanoparticles loaded with TNF siRNA suppress inflammation after intra-articular administration in a murine experimental arthritis model. Jansen MAA; Klausen LH; Thanki K; Lyngsø J; Skov Pedersen J; Franzyk H; Nielsen HM; van Eden W; Dong M; Broere F; Foged C; Zeng X Eur J Pharm Biopharm; 2019 Sep; 142():38-48. PubMed ID: 31199978 [TBL] [Abstract][Full Text] [Related]
6. Paclitaxel tumor priming promotes delivery and transfection of intravenous lipid-siRNA in pancreatic tumors. Wang J; Lu Z; Wang J; Cui M; Yeung BZ; Cole DJ; Wientjes MG; Au JL J Control Release; 2015 Oct; 216():103-10. PubMed ID: 26272765 [TBL] [Abstract][Full Text] [Related]
7. Preparation, Characterization, and In Vitro Evaluation of Lipidoid-Polymer Hybrid Nanoparticles for siRNA Delivery to the Cytosol. Thanki K; Zeng X; Foged C Methods Mol Biol; 2019; 1943():141-152. PubMed ID: 30838614 [TBL] [Abstract][Full Text] [Related]
8. A Polyethylenimine-Containing and Transferrin-Conjugated Lipid Nanoparticle System for Antisense Oligonucleotide Delivery to AML. Yuan Y; Zhang L; Cao H; Yang Y; Zheng Y; Yang XJ Biomed Res Int; 2016; 2016():1287128. PubMed ID: 27034925 [TBL] [Abstract][Full Text] [Related]
10. Anti prostate cancer therapy: Aptamer-functionalized, curcumin and cabazitaxel co-delivered, tumor targeted lipid-polymer hybrid nanoparticles. Chen Y; Deng Y; Zhu C; Xiang C Biomed Pharmacother; 2020 Jul; 127():110181. PubMed ID: 32416561 [TBL] [Abstract][Full Text] [Related]
11. Co-delivery of VEGF and Bcl-2 dual-targeted siRNA polymer using a single nanoparticle for synergistic anti-cancer effects in vivo. Lee SJ; Yook S; Yhee JY; Yoon HY; Kim MG; Ku SH; Kim SH; Park JH; Jeong JH; Kwon IC; Lee S; Lee H; Kim K J Control Release; 2015 Dec; 220(Pt B):631-41. PubMed ID: 26307351 [TBL] [Abstract][Full Text] [Related]
12. Effects of targeted nano-delivery systems combined with hTERT-siRNA and Bmi-1-siRNA on MCF-7 cells. Liu L; Li H; Zhang M; Lv X Int J Clin Exp Pathol; 2015; 8(6):6674-82. PubMed ID: 26261549 [TBL] [Abstract][Full Text] [Related]
13. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges. Gomes-da-Silva LC; Fonseca NA; Moura V; Pedroso de Lima MC; Simões S; Moreira JN Acc Chem Res; 2012 Jul; 45(7):1163-71. PubMed ID: 22568781 [TBL] [Abstract][Full Text] [Related]
14. Engineering of Solid Dosage Forms of siRNA-Loaded Lipidoid-Polymer Hybrid Nanoparticles Using a Quality-by-Design Approach. Lokras A; Foged C; Thakur A Methods Mol Biol; 2021; 2282():137-157. PubMed ID: 33928574 [TBL] [Abstract][Full Text] [Related]
15. Hydroxyapatite nanoparticles modified by branched polyethylenimine are effective non-viral vectors for siRNA transfection of hepatoma cells in vitro. Xu XL; Yang HY; Ou B; Lin SD; Wu H; He W; Jiang QC; Luo BM; Li GP Int J Oncol; 2015 May; 46(5):2138-42. PubMed ID: 25760143 [TBL] [Abstract][Full Text] [Related]
16. Nanoparticle-enabled, image-guided treatment planning of target specific RNAi therapeutics in an orthotopic prostate cancer model. Lin Q; Jin CS; Huang H; Ding L; Zhang Z; Chen J; Zheng G Small; 2014 Aug; 10(15):3072-82. PubMed ID: 24706435 [TBL] [Abstract][Full Text] [Related]